acit-1
Vaccineexperimental
Clinical trial activity
1 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 25, 2017 (NCT03096093)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- acit-1
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03096093 | Phase 1/Phase 2 (Phase 2) | Apr 25, 2017 | Cancer Research UK, Cancer Vaccines Limited, National Institute for Health Research, United Kingdom, Royal Liverpool & Broadgreen University Hospitals NHS Truts, University of Liverpool |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cancer Research UK | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Cancer Vaccines Limited | Academic/Hospital | 1 | 1 | 1 | 2017 |
| National Institute for Health Research, United Kingdom | Government | 1 | 0 | 1 | 2017 |
| Royal Liverpool & Broadgreen University Hospitals NHS Truts | Academic/Hospital | 1 | 0 | 1 | 2017 |
| University of Liverpool | Academic/Hospital | 1 | 0 | 1 | 2017 |
5 organizations
Page 1 / 1